Clinical Trial

Anti-inflammatory Activities of Vitamin C Supplementation on the Gut Barrier Function in Adults With Obesity

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 24, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is testing whether taking vitamin C every day can help improve gut health and reduce inflammation in adults with obesity. Poor gut health-sometimes called "leaky gut"-can allow harmful substances from bacteria to enter the bloodstream, which may lead to inflammation and increase the risk of heart disease and liver problems. Participants will complete two study periods, each lasting two weeks, with a two-week break in between. In one period, they will take vitamin C; in the other, a placebo. During each period, researchers will collect blood, urine, and stool samples, ask participants to track their diet and activity, and perform a test to measure gut permeability. There are minimal risks, such as discomfort from blood draws or temporary stomach upset from a sugar drink. While participants may not directly benefit, their involvement will help researchers learn whether vitamin C is a safe and effective way to improve gut health in people with obesity.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-27; most recent amendment 2025-10-22.
Status change: Not Yet Recruiting → Recruiting 2025-10-22
Trial Details
NCT Number NCT07151105
Lead Sponsor Ohio State University
Conditions Adequate Vitamin C Status, Inadequate Vitamin C Status
Enrollment 34 participants
Start Date 2025-10-01
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-10-24